Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
ABUS
ABUS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABUS News
Arbutus and Take-Two Options Trading Activity
5d ago
NASDAQ.COM
Moderna-Arbutus-Genevant Patent Agreement: Wall Street Views It as Suboptimal, Yet Alleviates Pressure on MRNA Shares
5d ago
stocktwits
Midday Market Moves: Notable Stock Fluctuations
5d ago
CNBC
Moderna Settles Patent Dispute with Arbutus and Genevant
5d ago
seekingalpha
STAAR Surgical Reports Disappointing Q4 Results, Shares Plummet
5d ago
Benzinga
Moderna Settles for $950 Million with Arbutus, Eyes Future Growth
5d ago
Benzinga
Movers: Moderna, CrowdStrike, GitLab, Coinbase, Strategy, Broadcom, and Others
6d ago
Barron's
Moderna Reaches Settlement in Lawsuit: Implications for Its Stock.
6d ago
Barron's
Moderna Shares Surge as Major Risk is Removed.
6d ago
Barron's
Box Inc Q4 Earnings Exceed Expectations
6d ago
Benzinga
Moderna Settles for Up to $2.25 Billion with Arbutus and Genevant
6d ago
stocktwits
Moderna Settles $2.25 Billion Patent Dispute with Genevant and Arbutus
6d ago
Newsfilter
Delaware Judge Dismisses Key Defenses in Moderna Patent Case
Feb 18 2026
seekingalpha
Arbutus Biopharma Shares Rise 10% After Patent Ruling
Feb 02 2026
seekingalpha
Health Care Stocks Decline as NYSE Health Care Index Eases 0.5%
Jan 16 2026
Yahoo Finance
Arbutus Biopharma (ABUS) Patent Revocation Leads to 18% Stock Crash
Jan 16 2026
stocktwits
Show More News
